Search

everythinglearnresearchcommunity

for

Search:↓

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Prepubertal girls have higher sex steroid levels than boys, possibly leading to earlier puberty.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Genital rejuvenation is becoming popular for improving genital appearance and function in both men and women.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Vitamin D receptor helps prevent skin tumors.

HPV16 oncogenes disrupt the normal activity of hair follicle stem cells.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

New treatments for male hypogonadism are effective and should be personalized.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Ovarian volume is significantly related to higher levels of certain hormones in Korean women with PCOS.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.